Literature DB >> 27114552

Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus.

Elliott H Sohn1, Hille W van Dijk2, Chunhua Jiao3, Pauline H B Kok4, Woojin Jeong3, Nazli Demirkaya4, Allison Garmager3, Ferdinand Wit5, Murat Kucukevcilioglu3, Mirjam E J van Velthoven6, J Hans DeVries7, Robert F Mullins3, Markus H Kuehn3, Reinier Otto Schlingemann4, Milan Sonka8, Frank D Verbraak9, Michael David Abràmoff10.   

Abstract

Diabetic retinopathy (DR) has long been recognized as a microvasculopathy, but retinal diabetic neuropathy (RDN), characterized by inner retinal neurodegeneration, also occurs in people with diabetes mellitus (DM). We report that in 45 people with DM and no to minimal DR there was significant, progressive loss of the nerve fiber layer (NFL) (0.25 μm/y) and the ganglion cell (GC)/inner plexiform layer (0.29 μm/y) on optical coherence tomography analysis (OCT) over a 4-y period, independent of glycated hemoglobin, age, and sex. The NFL was significantly thinner (17.3 μm) in the eyes of six donors with DM than in the eyes of six similarly aged control donors (30.4 μm), although retinal capillary density did not differ in the two groups. We confirmed significant, progressive inner retinal thinning in streptozotocin-induced "type 1" and B6.BKS(D)-Lepr(db)/J "type 2" diabetic mouse models on OCT; immunohistochemistry in type 1 mice showed GC loss but no difference in pericyte density or acellular capillaries. The results suggest that RDN may precede the established clinical and morphometric vascular changes caused by DM and represent a paradigm shift in our understanding of ocular diabetic complications.

Entities:  

Keywords:  diabetes; diabetic retinopathy; neurodegeneration; optical coherence tomography; retina

Mesh:

Year:  2016        PMID: 27114552      PMCID: PMC4868487          DOI: 10.1073/pnas.1522014113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  56 in total

1.  Improved method for obtaining 3-microns cryosections for immunocytochemistry.

Authors:  L K Barthel; P A Raymond
Journal:  J Histochem Cytochem       Date:  1990-09       Impact factor: 2.479

2.  Quantitative analysis of diabetic macular ischemia using optical coherence tomography.

Authors:  Dawn A Sim; Pearse A Keane; Simon Fung; Michael Karampelas; Srinivas R Sadda; Marcus Fruttiger; Praveen J Patel; Adnan Tufail; Catherine A Egan
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-21       Impact factor: 4.799

3.  Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1987-07       Impact factor: 12.079

4.  Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.

Authors:  A J Barber; E Lieth; S A Khin; D A Antonetti; A G Buchanan; T W Gardner
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

Review 5.  Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy.

Authors:  Erica L Fletcher; Joanna A Phipps; Michelle M Ward; Theresa Puthussery; Jennifer L Wilkinson-Berka
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

6.  Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy.

Authors:  Hille W van Dijk; Pauline H B Kok; Mona Garvin; Milan Sonka; J Hans Devries; Robert P J Michels; Mirjam E J van Velthoven; Reinier O Schlingemann; Frank D Verbraak; Michael D Abràmoff
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-17       Impact factor: 4.799

7.  The development of retinopathy in sucrose-fed and streptozotocin-diabetic rats.

Authors:  D Papachristodoulou; H Heath; S S Kang
Journal:  Diabetologia       Date:  1976-08       Impact factor: 10.122

8.  The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.

Authors: 
Journal:  Diabetes       Date:  1995-08       Impact factor: 9.461

9.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

10.  The db/db mouse: a useful model for the study of diabetic retinal neurodegeneration.

Authors:  Patricia Bogdanov; Lidia Corraliza; Josep A Villena; Andrea R Carvalho; José Garcia-Arumí; David Ramos; Jesús Ruberte; Rafael Simó; Cristina Hernández
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

View more
  159 in total

Review 1.  Diabetic retinopathy is a neurodegenerative disorder.

Authors:  Stephanie K Lynch; Michael D Abràmoff
Journal:  Vision Res       Date:  2017-04-28       Impact factor: 1.886

Review 2.  Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies.

Authors:  Sidra Zafar; Mira Sachdeva; Benjamin J Frankfort; Roomasa Channa
Journal:  Curr Diab Rep       Date:  2019-02-26       Impact factor: 4.810

3.  Intravitreal Fluocinolone Acetonide May Decelerate Diabetic Retinal Neurodegeneration.

Authors:  Stephanie K Lynch; Kyungmoo Lee; Zhi Chen; James C Folk; Ursula Schmidt-Erfurth; Bianca S Gerendas; Andreas Wahle; Charles C Wykoff; Michael D Abràmoff
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-05-01       Impact factor: 4.799

4.  PANRETINAL PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Comparison of Peripapillary Retinal Nerve Fiber Layer Thickness in a Randomized Clinical Trial.

Authors:  Lee M Jampol; Isoken Odia; Adam R Glassman; Carl W Baker; Anjali M Bhorade; Dennis P Han; Glenn J Jaffe; Michele Melia; Neil M Bressler; Angelo P Tanna
Journal:  Retina       Date:  2019-01       Impact factor: 4.256

5.  Plate-based Large-scale Cultivation of Caenorhabditis elegans: Sample Preparation for the Study of Metabolic Alterations in Diabetes.

Authors:  Katharina Kohl; Thomas Fleming; Kübra Acunman; Hans-Peter Hammes; Michael Morcos; Andrea Schlotterer
Journal:  J Vis Exp       Date:  2018-08-24       Impact factor: 1.355

6.  Inhibition of TLR4 alleviates the inflammation and apoptosis of retinal ganglion cells in high glucose.

Authors:  Lili Hu; Hongxia Yang; Ming Ai; Shuanghong Jiang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-08-14       Impact factor: 3.117

7.  Cone Photoreceptor Dysfunction in Early-Stage Diabetic Retinopathy: Association Between the Activation Phase of Cone Phototransduction and the Flicker Electroretinogram.

Authors:  J Jason McAnany; Jason C Park
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-01-02       Impact factor: 4.799

8.  Running on Trk to neuroprotection in diabetic retinopathy.

Authors:  Rithwick Rajagopal
Journal:  Eur J Neurosci       Date:  2018-05-15       Impact factor: 3.386

9.  Reduction of Glut1 in the Neural Retina But Not the RPE Alleviates Polyol Accumulation and Normalizes Early Characteristics of Diabetic Retinopathy.

Authors:  Nicholas C Holoman; Jacob J Aiello; Timothy D Trobenter; Matthew J Tarchick; Michael R Kozlowski; Emily R Makowski; Darryl C De Vivo; Charandeep Singh; Jonathan E Sears; Ivy S Samuels
Journal:  J Neurosci       Date:  2021-02-23       Impact factor: 6.167

10.  Functional changes in the neural retina occur in the absence of mitochondrial dysfunction in a rodent model of diabetic retinopathy.

Authors:  Dustin R Masser; Laura Otalora; Nicholas W Clark; Michael T Kinter; Michael H Elliott; Willard M Freeman
Journal:  J Neurochem       Date:  2017-10-20       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.